[Answered] Which of the following was the first large-scale digitally enabled transaction system in the B2C ...

This topic contains a solution. Click here to go to the answer

Author Question: Which of the following was the first large-scale digitally enabled transaction system in the B2C ... (Read 39 times)

ARLKQ

Hero Member
Posts: 571

on: Jul 7, 2018

Which of the following was the first large-scale digitally enabled transaction system in the B2C arena?

A) Telex
B) the Baxter Healthcare system
C) the French Minitel
D) EDI

Question 2

All of the following are issues facing Pinterest except:

A) copyright infringement.
B) inability to retain users.
C) spam.
D) scams.

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

brbarasa

Sr. Member
Posts: 308

Reply #1 on: Jul 7, 2018

Answer to Question 1

C

Answer to Question 2

B

ARLKQ

Member
Posts: 571

Reply 2 on: Jul 7, 2018

Gracias!

pratush dev

Member
Posts: 321

Reply 3 on: Yesterday

Thanks for the timely response, appreciate it

« previous next »

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

About one in five American adults and teenagers have had a genital herpes infection—and most of them don't know it. People with genital herpes have at least twice the risk of becoming infected with HIV if exposed to it than those people who do not have genital herpes.

Did you know?

Autoimmune diseases occur when the immune system destroys its own healthy tissues. When this occurs, white blood cells cannot distinguish between pathogens and normal cells.

Did you know?

Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.